Creative Planning Boosts Holdings in Humana Inc. $HUM

Creative Planning grew its stake in Humana Inc. (NYSE:HUMFree Report) by 20.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,282 shares of the insurance provider’s stock after purchasing an additional 5,404 shares during the quarter. Creative Planning’s holdings in Humana were worth $7,648,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Revolve Wealth Partners LLC purchased a new stake in Humana during the 4th quarter valued at about $202,000. Private Advisor Group LLC acquired a new position in shares of Humana during the 1st quarter worth approximately $443,000. Kestra Private Wealth Services LLC boosted its holdings in shares of Humana by 4.1% during the 1st quarter. Kestra Private Wealth Services LLC now owns 2,648 shares of the insurance provider’s stock worth $701,000 after purchasing an additional 105 shares during the last quarter. Teachers Retirement System of The State of Kentucky grew its position in shares of Humana by 4.0% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 9,293 shares of the insurance provider’s stock valued at $2,459,000 after purchasing an additional 361 shares in the last quarter. Finally, HighPoint Advisor Group LLC increased its holdings in shares of Humana by 15.2% in the first quarter. HighPoint Advisor Group LLC now owns 1,739 shares of the insurance provider’s stock valued at $451,000 after purchasing an additional 230 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

Several research firms recently issued reports on HUM. The Goldman Sachs Group began coverage on shares of Humana in a research report on Tuesday, October 14th. They set a “sell” rating and a $235.00 price objective for the company. Barclays dropped their price target on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a research note on Friday, October 3rd. Wall Street Zen lowered shares of Humana from a “buy” rating to a “hold” rating in a research report on Saturday, August 2nd. Truist Financial decreased their price objective on Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a report on Monday, November 10th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research report on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $298.39.

Check Out Our Latest Stock Report on HUM

Humana Stock Performance

NYSE:HUM opened at $228.94 on Thursday. The company has a market cap of $27.53 billion, a price-to-earnings ratio of 17.57, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The company has a fifty day simple moving average of $267.88 and a two-hundred day simple moving average of $257.49.

Humana (NYSE:HUMGet Free Report) last announced its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business had revenue of $32.65 billion during the quarter, compared to the consensus estimate of $31.99 billion. During the same period in the previous year, the company posted $4.16 earnings per share. The business’s revenue for the quarter was up 11.1% on a year-over-year basis. As a group, equities analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s dividend payout ratio (DPR) is 33.18%.

Humana Company Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.